Fluticasone Nasal Spray Suppliers & Bulk Manufacturers
Available Forms: Spray
Available Strengths: 50 mcg/Spray
Reference Brands: Flonase(US & EU)
Category:
ENT
Fluticasone nasal spray is a corticosteroid that reduces inflammation by suppressing immune responses in the nasal passages. It alleviates allergy symptoms like congestion, sneezing, and runny nose. Benefits include symptom relief, improved breathing, decreased nasal inflammation, and enhanced quality of life in allergy sufferers worldwide.
Fluticasone Nasal Spray is available in Spray
and strengths such as 50 mcg/Spray.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Fluticasone Nasal Spray is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Fluticasone Nasal Spray can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Fluticasone nasal spray, marketed as Flonase in the US and Flixonase in the EU, is approved for allergic rhinitis and nasal inflammation. Regulatory approval requires dossiers covering clinical efficacy, safety data, manufacturing practices, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper adherence supports swift approval, safe use, and broad availability, helping millions worldwide effectively manage allergies and nasal conditions through high-quality nasal corticosteroid formulations supported by regional regulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing